The ruling blocks Lupin and Zydus Life from selling their generic version of Mirabegron, the bioequivalent of Astellas' ...

A sudden rollback of federal funding for public health research has jolted the US pharma landscape. With governors in 23 US states questioning the rollback, India sees both a warning and an ...